4.7 Article

Regulation of the high basal expression of the manganese superoxide dismutase gene in aggressive breast cancer cells

Journal

FREE RADICAL BIOLOGY AND MEDICINE
Volume 50, Issue 12, Pages 1771-1779

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2011.03.013

Keywords

Manganese superoxide dismutase; Breast cancer; Transcription; Sp1; NF-kappa B; Damaged DNA binding 2; Histone modifications; Free radicals

Funding

  1. Ligue contre le Cancer (Comites Meuse and Meurthe et Moselle)
  2. Universite Henri Poincare-Nancy Universite
  3. Region Lorraine
  4. French Research Ministry
  5. Ligue contre le Cancer (Comite de Meurthe et Moselle)

Ask authors/readers for more resources

A high basal expression of manganese superoxide dismutase (MnSOD) has been reported in aggressive breast cancer cells, according to an unknown mechanism, and contributes to their invasive abilities. Here, we report the involvement of Sp1 and nuclear factor-kappa B (NF-kappa B) transcription factors in this high basal expression of MnSOD in aggressive breast cancer cells. Suppression or inactivation of Sp1 showed that it plays an essential role in the high MnSOD expression in aggressive breast cancer cells through a unique binding site identified by chromatin immunoprecipitation (ChIP) assay and functional analysis of the MnSOD proximal promoter. Treatment of cells with a specific NF-kappa B inhibitor peptide decreased significantly high basal MnSOD expression. A ChIP assay showed binding of a constitutive p50/p65 NF-kappa B complex to the MnSOD intronic enhancer element, associated with hyperacetylation of the H3 histone. Finally, high basal expression of MnSOD resulted in the lack of expression of Damaged DNA binding 2 (DDB2) protein in aggressive breast cancer cells. DDB2 overexpression prevented the binding of Sp1 as well as of NF-kappa B to their respective elements on the MnSOD gene. These results contribute to a better understanding of MnSOD up-regulation, which may be clinically important in the prediction of breast tumor progression. (C) 2011 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available